FDA
The new article provides further clarifications related to gathering additional information.
FDA
The new article highlights the key aspects related to the way test articles should be extracted in order to ensure the accuracy and reliability of further assessment.
FDA
The new article explains in detail the way chemical analysis should be conducted in order to ensure any and all key matters are addressed properly.
FDA
The final article of the cycle provides additional clarifications regarding the matters related to data reporting.
Medsafe
The new article describes in detail the application process to be followed by the interested parties when applying for authorisations in the context of clinical trials.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
